JCR Pharmaceuticals , Ltd. Intangible Assets

The latest intangible assets for JCRRF is $2.5B as of June 2026. That compares with $2.8B in the prior-year period — down 11.7% year over year. Investors often review this figure alongside JCR Pharmaceuticals , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, JCRRF's intangible assets moved from $2.8B to $2.5B — a 11.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in JCR Pharmaceuticals , Ltd.'s operating scale or balance-sheet position.

A intangible assets figure of $2.5B for JCRRF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting JCRRF's intangible assets ($2.5B), review year-over-year change from $2.8B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.